SuperworthIradimed EPS IRMD
Diluted earnings per share by quarter and over the last twelve months, from 2013.
- Last 12 months, to Jun 30, 2026
- $1.79
- Latest quarter, Q2 FY26
- $0.41
- −9% on a year earlier
- Fiscal year 2025
- $1.75
- +17% on the year before
Iradimed's earnings per share was $1.79 over the twelve months to Jun 30, 2026, up 10% on a year earlier.
In its latest quarter, Q2 FY26, it was $0.41, down 9% on the same quarter a year before.
Over the five fiscal years to FY2025 it grew 74% a year on average.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | $1.75 | +17% |
| FY2024 | $1.50 | +10% |
| FY2023 | $1.36 | +33% |
| FY2022 | $1.02 | +38% |
| FY2021 | $0.74 | +573% |
| FY2020 | $0.11 | −86% |
| FY2019 | $0.78 | +50% |
| FY2018 | $0.52 | +940% |
| FY2017 | $0.05 | −92% |
| FY2016 | $0.61 | +2% |
| FY2015 | $0.60 | +186% |
| FY2014 | $0.21 | −9% |
| FY2013 | $0.23 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | $0.41 | −9% | $1.79 | |
| Q1 FY26 | $0.45 | +22% | $1.83 | |
| Q4 FY25 | $0.50 | +25% | $1.75 | |
| Q3 FY25 | $0.43 | +8% | $1.65 | |
| Q2 FY25 | $0.45 | +18% | $1.62 | |
| Q1 FY25 | $0.37 | +16% | $1.55 | |
| Q4 FY24 | $0.40 | +11% | $1.50 | |
| Q3 FY24 | $0.40 | +0% | $1.46 | |
| Q2 FY24 | $0.38 | +15% | $1.46 | |
| Q1 FY24 | $0.32 | +19% | $1.41 | |
| Q4 FY23 | $0.36 | +24% | $1.36 | |
| Q3 FY23 | $0.40 | +48% | $1.29 |
Against its peers
Companies in Medical - Instruments & Supplies nearest Iradimed's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| IRMDIradimed | $1.79 | +10% a year |
| STAAStaar Surgical | $0.07 | |
| BVSBioventus | $0.77 | |
| CDRECadre | $0.81 | −14% a year |
| EYENational Vision | $0.61 | |
| MOVMovado | $1.80 | +137% a year |
| LMATLemaitre Vascular | $2.85 | +38% a year |
| INSPInspire Medical Systems | $4.62 | +166% a year |
| MDXGMimedx | $0.04 | −81% a year |
| TCMDTactile Systems Technology | $1.08 | +74% a year |
| UFPTUFP Technologies | $9.28 | +8% a year |
| Peer median | $0.94 |
Where Iradimed ranks
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Iradimed
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.